Related Experiment Video
Updated: Mar 22, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Predictive value of newly defined CHA2DS2-VASc-HSF score for severity of coronary artery disease in ST segment
Onur Kadir Uysal1, Caner Turkoglu, Mustafa Duran
1Adana Numune Education and Research Hospital, Adana, Turkey. onurkadir@gmail.com.
Insights
The CHA2DS2-VASc-HSF score effectively predicts coronary artery disease (CAD) severity in ST-segment elevation myocardial infarction (STEMI) patients. This score aids in assessing atherosclerosis extent, crucial for STEMI management.
Area of Science:
- Cardiology
- Vascular Medicine
- Clinical Risk Stratification
Background:
- Established risk scores like CHADS2 and CHA2DS2-VASc share factors with coronary artery disease (CAD) development.
- The CHA2DS2-VASc-HSF score incorporates factors known to promote atherosclerosis and CAD severity.
Purpose of the Study:
- To evaluate the association between the CHA2DS2-VASc-HSF score and CAD severity.
- CAD severity was assessed using the SYNTAX score (SxS) in patients experiencing ST-segment elevation myocardial infarction (STEMI).
Main Methods:
- 454 STEMI patients undergoing primary percutaneous coronary intervention were analyzed.
- Patients were stratified into tertiles based on SYNTAX score (SxS): low (<14), intermediate (14-20), and high (≥21).
Main Results:
- CHADS2, CHA2DS2-VASc, and CHA2DS2-VASc-HSF scores showed significant differences across SxS groups (p<0.001).
- Multivariate analysis confirmed CHA2DS2-VASc-HSF score as an independent predictor of high SxS (OR 1.258, p=0.028), alongside age and ejection fraction.
Conclusions:
- The CHA2DS2-VASc-HSF score is a novel predictor of atherosclerosis severity.
- This score holds significant value for risk stratification in STEMI patients.
Background:
CHADS2 and CHA2DS2-VASc scores are widely used in clinical practice and include similar risk factors for the development of coronary artery disease (CAD). It is known that the factors comprising the newly defined CHA2DS2-VASc-HSF score promote atherosclerosis and are associated with severity of CAD.
Aim:
To investigate the association of the CHA2DS2-VASc-HSF score with the severity of CAD as assessed by SYNTAX score (SxS) in patients with ST segment elevation myocardial infarction (STEMI).
Methods:
A total of 454 consecutive patients with STEMI (males 79%, mean age 57.3 ± 12.9 years), who underwent primary percutaneous coronary intervention were included in our study. The patients were divided into three groups according to the SxS tertiles: low SxS group (SxS < 14; 151 patients), intermediate SxS group (SxS 14-20; 152 patients), and high SxS group (SxS ≥ 21; 151 patients).
Results:
The CHADS2, CHA2DS2-VASc, and CHA2DS2VASc-HSF scores were found to be significantly different among the SxS groups (p < 0.001, p < 0.001, and p < 0.001). After multivariate analysis, the CHA2DS2-VASc-HSF score was associated with high SxS (odds ratio [OR] 1.258, 95% confidence interval [CI] 1.026-1.544; p = 0.028) together with age (OR 1.032, 95% CI 1.013-1.050; p = 0.001) and ejection fraction (OR 0.927, 95% CI 0.901-0.955; p < 0.001).
Conclusions:
A newly diagnosed CHA2DS2-VASc-HSF score predicts the severity of atherosclerosis in patients with STEMI.
More Related Videos
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease I: Introduction